We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Nmc Health Plc | LSE:NMC | London | Ordinary Share | GB00B7FC0762 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 938.40 | 940.00 | 941.60 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMNMC
RNS Number : 0663T
NMC Health Plc
15 March 2019
NMC Health plc
Grant of options
London, 15 March 2019: NMC Health plc ("NMC", the "Company" or the "Group"), the leading private healthcare operator in the Gulf Cooperation Council (GCC) with international services across 19 countries, announces that on 15 March 2019 it granted awards over a total of 237,538 Ordinary shares under its Long-Term Incentive Plan.
These awards, by way if nil-cost options, were made to Directors and PDMRs of the Company as follows:
Name of individual Director / PDMR Number of shares subject to award Prasanth Manghat Director 73,425 ----------------- ---------------------------------- Khalifa Bin Butti Director 43,846 ----------------- ---------------------------------- Hani Buttikhi Director 32,369 ----------------- ---------------------------------- Prasanth Shenoy PDMR 26,003 ----------------- ---------------------------------- Michael Davis PDMR 19,502 ----------------- ---------------------------------- Dr. Chandrakumari Shetty PDMR 26,913 ----------------- ---------------------------------- Simon Watkins PDMR 15,480 ----------------- ----------------------------------
The vesting of all the awards granted under the LTIP referred to above are subject to the achievement of performance targets relating to the Company's EBITDA growth and total shareholder return (relative to a comparator group) over a three-year performance period.
In addition, the vesting of all the awards granted will be subject to performance against an additional underpin capturing the conversion of EBITDA to net income to provide shareholders with an aggregate view on earnings, cash flow, and capital efficiency. Failure to meet the underpin will reduce the proportion of these LTIP awards vesting by 50%. The awards are also granted subject to an additional holding period of two years applying after any vesting of the awards during which award holders cannot exercise vested awards.
This notification is made in accordance with the Market Abuse Regulation.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1 Details of the person discharging managerial responsibilities / person closely associated a) Name Mr Prasanth Manghat Mr Khalifa Bin Butti Mr Hani Buttikhi Mr Prashanth Shenoy Mr Michael Davis Dr Chandrakumari Shetty Mr Simon Watkins ------------------------ -------------------------------------- 2 Reason for the notification ---------------------------------------------------------------- a) Position/status Directors and PDMRs of the Company ------------------------ -------------------------------------- b) Initial notification Initial notification /Amendment ------------------------ -------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ---------------------------------------------------------------- a) Name NMC Health plc ------------------------ -------------------------------------- b) LEI 2138008YQEVWBE1V2M52 ------------------------ -------------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ---------------------------------------------------------------- a) Description Options over Ordinary Shares of the financial instrument, type of instrument ISIN: GB00B7FC0762 Identification code ------------------------ -------------------------------------- b) Nature of Grant of nil-cost options the transaction ----------------- -------------------------- c) Price(s) and Price No. of shares volume(s) 0p 73,425 -------------- 0p 43,846 -------------- 0p 32,369 -------------- 0p 26,003 -------------- 0p 19,502 -------------- 0p 26,913 -------------- 0p 15,480 -------------- ----------------- -------------------------- d) Aggregated N/A information - volume - Price - Total ----------------- -------------------------- e) Date of the 15 March 2019 transaction ----------------- -------------------------- f) Place of the Not on a trading venue transaction ----------------- --------------------------
Contacts
NMC Simon Watkins, Group Company Secretary +44 (0)20 3205 7313 Media FTI Consulting, London Brett Pollard +44 (0)20 3727 1100 FTI Consulting, Gulf Shane Dolan +971 (0)4 437 2100
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHJAMITMBIBBJL
(END) Dow Jones Newswires
March 15, 2019 10:49 ET (14:49 GMT)
1 Year Nmc Health Chart |
1 Month Nmc Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions